REAP-guided engineering improves P450 BM3 activity
REAP combines a protein-language-model ranking predictor with active selection and automated build-and-test cycles. The study reports a P450 BM3 quintuple variant with 57-fold higher product yield than the engineered FL#62 starting scaffold in its high-throughput assay. This is a variant-specific comparison with an already engineered scaffold, not a 57-fold gain over wild type. A separate sortase result is not included in this bounded draft.
Technology: REAP; PLM-RankReg; automated build-and-test
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Publisher indexed article reports a quintuple variant and 57-fold product-yield increase over FL#62 in the high-throughput assay; kinetic characterization is also described.
- Still unknown: Independent replication and broader application are not established by this bounded review.
- AI role: Learned ranking and active selection nominate variants for automated synthesis and testing; the reported gain is measured against the engineered FL#62 scaffold.
Evidence sources: https://www.nature.com/articles/s41467-026-76264-2
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 16 Nov 2026. Review scope: Publisher indexed primary article text, title/DOI and result; PMC direct open CAPTCHA challenged. Journal/preprint chronology and sequence overlap not audited..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.